Related Experiment Video

Updated: Aug 11, 2026

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions
10:10

Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions

Published on: May 28, 2017

Fragile sites are preferential targets for integrations of MLV vectors in gene therapy

A C Bester1, M Schwartz, M Schmidt

  • 1Department of Genetics, Silberman Life Sciences Institute, Hebrew University, Jerusalem, Israel.

Gene Therapy
|March 3, 2006
PubMed

Insights

Gene therapy for SCID-X1 using a retroviral vector led to leukemia in two patients due to vector DNA integrating near the LMO2 gene. These integrations occurred at common fragile sites, revealing a potential risk in gene therapy.

Area of Science:

  • Genetics
  • Oncology
  • Virology

Background:

  • Gene therapy for Severe Combined Immunodeficiency X-linked (SCID-X1) utilizes viral vectors.
  • Murine leukemia virus (MLV)-derived vectors have been employed in SCID-X1 gene therapy.
  • Activating vector integrations near oncogenes can pose risks, including leukemia development.

Purpose of the Study:

  • To investigate the mechanism behind vector integration in SCID-X1 gene therapy.
  • To understand the nonrandom distribution of vector integrations observed in patients.
  • To assess the implications of integration sites on the risk-benefit ratio of MLV-based gene therapy.

Main Methods:

  • Analysis of vector integration sites in patients who developed leukemia post-gene therapy.
  • Characterization of common fragile sites, specifically FRA11E.
  • Correlation of MLV integration patterns with fragile site locations.

Main Results:

  • Two patients treated for SCID-X1 developed leukemia due to MLV vector integration near the LMO2 gene.
  • Vector integrations were found to cluster within FRA11E, a known common fragile site.
  • Common fragile sites were identified as nonrandom targets for MLV integrations.

Conclusions:

  • Common fragile sites are preferential integration sites for MLV vectors.
  • This nonrandom integration mechanism contributes to the risk of insertional mutagenesis and leukemia in gene therapy.
  • Understanding integration site preferences is crucial for improving the safety of viral vector-based gene therapies.

More Related Videos

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA11:58

Linear Amplification Mediated PCR – Localization of Genetic Elements and Characterization of Unknown Flanking DNA

Published on: June 25, 2014

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites09:31

Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites

Published on: March 22, 2016

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...